TY  - CONF

T1  - Pharmacolkinetics (PK) and pharmacodynamics (PD) of AMG 162, a fully human monoclonal antibody to receptor activator of NF kappa B ligand (RANKL), following a single subcutaneous dose to patients with cancer-related bone

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2004/07/15

AU  - Peterson MC

AU  - Martin SW

AU  - Stouch B

AU  - Chen D

AU  - Holloway DL

AU  - Body JJ

AU  - Lipton A

AU  - Coleman R

AU  - Bekker PJ

ED  - 

VL  - 22

IS  - 14

SP  - 755S

EP  - 755S

Y2  - 2025/10/10

ER  -